Literature DB >> 23657117

Skeletal dysplasias with increased bone density: evolution of molecular pathogenesis in the last century.

Shagun Aggarwal1.   

Abstract

Skeletal dysplasias (SKD) with increased bone density form a discrete group of SKDs as per the Nosology and Classification of Genetic Skeletal Disorders, 2010 Revision. This group, with the prototype disorder being osteopetrosis, has evolved over the last century, with new entities being described & their molecular basis being increasingly elucidated. Osteopetrosis, which remained an enigma in the early part of its description, is now known to be genetically heterogenous. Other disorders in this group, which were initially described as variant forms of osteopetrosis, are now recognised to be distinct conditions. However, all these SKDs with increased bone density share their molecular pathogenesis as majority arise due to mutations in the genes governing osteoclast formation and function.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AD; ANKH; AR; Autosomal dominant; Autosomal recessive; CA2; CLCN7; FERMT3; Genetics; History; Increased bone density; LEM domain containing 3 [Homo sapiens]; LEMD3; LRP5; NEMO; NF-kappa-B essential modulator [Homo sapiens]; OSTM1; Osteopetrosis; PLEKHM1; RANK; RANKL; SKD; SLC29A3; SNX10; SOST; Skeletal dysplasia; T-cell, immune regulator 1, ATPase, H(+) transporting, lysosomal V0 subunit A3 [Homo sapiens]; TCIRG1; TGFB1; WTX; Wilms tumor gene on the X chromosome protein [Homo sapiens]; ankylosis, progressive homolog (mouse) [Homo sapiens]; carbonic anhydrase II [Homo sapiens]; chloride channel, voltage-sensitive 7 [Homo sapiens]; fermitin family member 3 [Homo sapiens]; low density lipoprotein receptor-related protein 5 [Homo sapiens]; osteopetrosis associated transmembrane protein 1 [Homo sapiens]; pleckstrin homology domain containing, family M (with RUN domain) member 1 [Homo sapiens]; receptor activator of NF-KB [Homo Sapiens]; receptor activator of nuclear factor kappa B ligand [Homo Sapiens]; sclerostin [Homo sapiens]; solute carrier family 29 (nucleoside transporters), member 3 [Homo sapiens]; sorting nexin 10 [Homo sapiens]; transforming growth factor, beta 1 [Homo sapiens]

Mesh:

Substances:

Year:  2013        PMID: 23657117     DOI: 10.1016/j.gene.2013.04.069

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  Rapid skeletal turnover in a radiographic mimic of osteopetrosis.

Authors:  Michael P Whyte; Katherine L Madson; Steven Mumm; William H McAlister; Deborah V Novack; Jo C Blair; Timothy R Helliwell; Marina Stolina; Laurence J Abernethy; Nicholas J Shaw
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

2.  Hematopoietic cell transplantation for a child with OSTM1 osteopetrosis.

Authors:  Kathleen M Overholt; Melissa J Rose; Sarita Joshi; Gail E Herman; Rajinder Bajwa; Rolla Abu-Arja; Hemalatha G Rangarajan; Edwin M Horwitz
Journal:  Blood Adv       Date:  2016-12-30

Review 3.  Identification of a novel LEMD3 Y871X mutation in a three-generation family with osteopoikilosis and review of the literature.

Authors:  Q Zhang; Z H Mo; C S Dong; F Yang; Y H Xie; P Jin
Journal:  J Endocrinol Invest       Date:  2015-12-22       Impact factor: 4.256

4.  Novel CLCN7 mutation identified in a Han Chinese family with autosomal dominant osteopetrosis-2.

Authors:  Hao Deng; Dan He; Pengfei Rong; Hongbo Xu; Lamei Yuan; Liu Li; Qian Lu; Yi Guo
Journal:  Mol Pain       Date:  2016-06-20       Impact factor: 3.395

Review 5.  A review of skeletal dysplasia research in India.

Authors:  A Uttarilli; H Shah; A Shukla; K M Girisha
Journal:  J Postgrad Med       Date:  2018 Apr-Jun       Impact factor: 1.476

Review 6.  Critical Roles of NF-κB Signaling Molecules in Bone Metabolism Revealed by Genetic Mutations in Osteopetrosis.

Authors:  Eijiro Jimi; Takenobu Katagiri
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

7.  Autosomal dominant osteopetrosis associated with renal tubular acidosis is due to a CLCN7 mutation.

Authors:  Sian E Piret; Caroline M Gorvin; Anne Trinh; John Taylor; Stefano Lise; Jenny C Taylor; Peter R Ebeling; Rajesh V Thakker
Journal:  Am J Med Genet A       Date:  2016-08-19       Impact factor: 2.802

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.